Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
10
Métodos estadísticos
7
Ensayos clínicos
6
Investigaciones
6
Metodología
6
Pruebas clínicas
5
Práctica de juicios
5
Blues (Música)
3
Cáncer
3
Ensayos clinicos
3
Administración de justicia
2
Asesinato
2
Biografía
2
Civilización
2
Delitos políticos
2
Derecho
2
Diseño de investigación
2
Estados Unidos
2
Estadística
2
Evolución (Biología)
2
Libretos para óperas
2
Literatura inglesa
2
Medicina
2
Novela alemana
2
Novela estadounidense
2
Novela inglesa
2
Oncología
2
Orientación profesional
2
Política y gobierno
2
Quimioterapia
2
-
342601por Guisado-Vasco, Pablo, Valderas-Ortega, Sofia, Carralón-González, Maria Maravillas, Roda-Santacruz, Ana, González-Cortijo, Lucia, Sotres-Fernández, Gabriel, Martí-Ballesteros, Eva María, Luque-Pinilla, José Manuel, Almagro-Casado, Elena, La Coma-Lanuza, Félix J., Barrena-Puertas, Ruth, Malo-Benages, Esteban Javier, Monforte-Gómez, María José, Diez-Munar, Rocío, Merino-Lanza, Esther, Comeche-Casanova, Lorena, Remirez-de-Esparza-Otero, Margarita, Correyero-Plaza, María, Recio-Rodríguez, Manuel, Rodríguez-López, Margarita, Sánchez-Manzano, María Dolores, Andreu-Vázquez, Cristina, Thuissard-Vasallo, Israel John, María-Tomé, José María Echave-Sustaeta, Carnevali-Ruiz, Daniel“…Our findings might entail relevant implications for the therapy of this disease and could boost the design of new clinical trials among subjects affected by severe COVID-19. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342602por Choi, Yoonha, Qu, Jianghan, Wu, Shuyang, Hao, Yangyang, Zhang, Jiarui, Ning, Jianchang, Yang, Xinwu, Lofaro, Lori, Pankratz, Daniel G., Babiarz, Joshua, Walsh, P. Sean, Billatos, Ehab, Lenburg, Marc E., Kennedy, Giulia C., McAuliffe, Jon, Huang, Jing“…The BGC was trained and validated on patients in the Airway Epithelial Gene Expression in the Diagnosis of Lung Cancer (AEGIS) trials. A modern patient cohort, the BGC Registry, showed differences in key clinical factors from the AEGIS cohorts, with less smoking history, smaller nodules and older age. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342603por Klarin, Derek, Verma, Shefali Setia, Judy, Renae, Dikilitas, Ozan, Wolford, Brooke N., Paranjpe, Ishan, Levin, Michael G., Pan, Cuiping, Tcheandjieu, Catherine, Spin, Joshua M., Lynch, Julie, Assimes, Themistocles L., Åldstedt Nyrønning, Linn, Mattsson, Erney, Edwards, Todd L., Denny, Josh, Larson, Eric, Lee, Ming Ta Michael, Carrell, David, Zhang, Yanfei, Jarvik, Gail P., Gharavi, Ali G., Harley, John, Mentch, Frank, Pacheco, Jennifer A., Hakonarson, Hakon, Skogholt, Anne Heidi, Thomas, Laurent, Gabrielsen, Maiken Elvestad, Hveem, Kristian, Nielsen, Jonas Bille, Zhou, Wei, Fritsche, Lars, Huang, Jie, Natarajan, Pradeep, Sun, Yan V., DuVall, Scott L., Rader, Daniel J., Cho, Kelly, Chang, Kyong-Mi, Wilson, Peter W.F., O’Donnell, Christopher J., Kathiresan, Sekar, Scali, Salvatore T., Berceli, Scott A., Willer, Cristen, Jones, Gregory T., Bown, Matthew J., Nadkarni, Girish, Kullo, Iftikhar J., Ritchie, Marylyn, Damrauer, Scott M., Tsao, Philip S.“…Using this PRS, we identified a subset of the population with AAA prevalence greater than that observed in screening trials informing current guidelines. CONCLUSIONS: We identify novel AAA genetic associations with therapeutic implications and identify a subset of the population at significantly increased genetic risk of AAA independent of family history. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342604por Allanore, Yannick, Bozzi, Sylvie, Terlinden, Augustin, Huscher, Doerte, Amand, Caroline, Soubrane, Christina, Siegert, Elise, Czirják, László, Carreira, Patricia E., Hachulla, Eric, Zanatta, Elisabetta, Li, Mengtao, Airò, Paolo, Mendoza, Fabian A., Rosato, Edoardo, Distler, Oliver“…This European Scleroderma Trials and Research (EUSTAR) database analysis was undertaken to examine the importance of impaired functionality in dcSSc prognosis. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342605por Belvedere, Claudio, Giacomozzi, Claudia, Carrara, Claudio, Lullini, Giada, Caravaggi, Paolo, Berti, Lisa, Marchesini, Giulio, Baccolini, Luca, Durante, Stefano, Leardini, Alberto“…Pressure patterns were also acquired during barefoot level walking at self-selected speed, from which regional peak pressure and absolute and normalised pressure-time integral were worked out at hallux and at first, central and fifth metatarsals (LOAD variables) as averaged over five trials. Correlations with 3D alignments were searched also with arch index, contact time, age, BMI, years of disease and a neuropathy-related variable. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342606por Bline, Katherine E., Moore-Clingenpeel, Melissa, Hensley, Josey, Steele, Lisa, Greathouse, Kristin, Anglim, Larissa, Hanson-Huber, Lisa, Nateri, Jyotsna, Muszynski, Jennifer A., Ramilo, Octavio, Hall, Mark W.“…Prospective clinical trials using a priori immunophenotyping are needed to understand optimal hydrocortisone strategies in this population.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342607por Tsai, Alice, Wu, Shu-Pei, Haseltine, Eric, Kumar, Sanjeev, Moskowitz, Samuel M., Panorchan, Paul, Shah, Kushal“…INTRODUCTION: The triple-combination (TC) cystic fibrosis transmembrane conductance regulator (CFTR) modulator regimen elexacaftor, tezacaftor, and ivacaftor was shown to be safe and efficacious in phase 3 trials of people with cystic fibrosis (pwCF) ≥ 12 years of age with ≥ 1 F508del-CFTR allele. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342608“…Since the utility of cross-sectional studies for causal inference remains limited, both randomized controlled trials and prospective cohort studies are needed to better evaluate contributions of e-cigarettes as harm reduction tools for smokers.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342609por Jordan, Roberta I., Allsop, Matthew J., ElMokhallalati, Yousuf, Jackson, Catriona E., Edwards, Helen L., Chapman, Emma J., Deliens, Luc, Bennett, Michael I.“…Following PRISMA guidelines, articles were screened using inclusion (any study design reporting duration from initiation to death in adults palliative care services) and exclusion (paediatric/non-English language studies, trials influencing the timing of palliative care) criteria. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342610por Jin, Xuan, Kim, Moo Hyun, Han, Ki Hoon, Hong, Soon Jun, Ahn, Jeong‐Cheon, Sung, Jung‐Hoon, Cho, Jin‐Man, Lee, Han Cheol, Choi, So‐Yeon, Lee, Kyounghoon, Kim, Woo‐Shik, Rhee, Moo‐Yong, Kim, Ju Han, Hong, Seung Pyo, Yoo, Byung Su, Cho, Eun Joo, Lee, Jae‐Hwan, Kim, Pum‐Joon, Park, Chang‐Gyu, Hyon, Min Su, Shin, Jin Ho, Lee, Sang Hyun, Sung, Ki Chul, Hwang, Jinyong, Kwon, Kihwan, Chae, In‐Ho, Seo, Jeong‐Sook, Kim, Hyungseop, Lee, Hana, Cho, Yoonhwa, Kim, Hyo‐Soo“…Combined administration of telmisartan/amlodipine 80/5 mg and rosuvastatin 20 mg for the treatment of hypertensive patients with dyslipidemia significantly reduces blood pressure and improves lipid control. ClinicalTrials.gov identifier: NCT03067688.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342611por D’Arrigo, Sonia, Sandroni, Claudio, Cacciola, Sofia, Dell’Anna, Antonio Maria, Pittiruti, Mauro, Annetta, Maria Giuseppina, Colosimo, Cesare, Antonelli, Massimo“…CONCLUSIONS: During hemodynamic monitoring with TPTD, both single-lumen 5Fr PICCs and triple-lumen 6Fr PICCs can be used for cold fluid bolus injection as an alternative to CICC (ClinicalTrials.gov NCT04241926).…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342612por Santos, Joseph Alvin, Li, Ka Chun, Huang, Liping, Mclean, Rachael, Petersen, Kristina, Di Tanna, Gian Luca, Webster, Jacqui“…METHODS: Studies were systematically identified through searches of peer-reviewed databases (Medline, Embase, Global Health, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews) and grey literature. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342613por Lund, Maria E., Howard, Christopher B., Thurecht, Kristofer J., Campbell, Douglas H., Mahler, Stephen M., Walsh, Bradley J.“…Miltuximab(®) is a clinical stage anti-GPC-1 antibody that has proven safe in first in human trials. METHODS: The single chain variable fragment (scFv) of Miltuximab(®) and the CD3 binding sequence of Blinatumomab were combined in a standard BiTE format. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342614por Ricci, Giulia, Mele, Fabiano, Govi, Monica, Ruggiero, Lucia, Sera, Francesco, Vercelli, Liliana, Bettio, Cinzia, Santoro, Lucio, Mongini, Tiziana, Villa, Luisa, Moggio, Maurizio, Filosto, Massimiliano, Scarlato, Marina, Previtali, Stefano C., Tripodi, Silvia Maria, Pegoraro, Elena, Telese, Roberta, Di Muzio, Antonio, Rodolico, Carmelo, Bucci, Elisabetta, Antonini, Giovanni, D’Angelo, Maria Grazia, Berardinelli, Angela, Maggi, Lorenzo, Piras, Rachele, Maioli, Maria Antonietta, Siciliano, Gabriele, Tomelleri, Giuliano, Angelini, Corrado, Tupler, Rossella“…These evidences are also fundamental for the stratification of patients eligible for clinical trials. Our work reinforces the value of large genotype–phenotype studies to define criteria for clinical practice and genetic counseling in rare diseases.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342615por Rentsch, Christopher T, DeVito, Nicholas J, MacKenna, Brian, Morton, Caroline E, Bhaskaran, Krishnan, Brown, Jeremy P, Schultze, Anna, Hulme, William J, Croker, Richard, Walker, Alex J, Williamson, Elizabeth J, Bates, Chris, Bacon, Seb, Mehrkar, Amir, Curtis, Helen J, Evans, David, Wing, Kevin, Inglesby, Peter, Mathur, Rohini, Drysdale, Henry, Wong, Angel Y S, McDonald, Helen I, Cockburn, Jonathan, Forbes, Harriet, Parry, John, Hester, Frank, Harper, Sam, Smeeth, Liam, Douglas, Ian J, Dixon, William G, Evans, Stephen J W, Tomlinson, Laurie, Goldacre, Ben“…Therefore, completion of randomised trials investigating pre-exposure prophylactic use of hydroxychloroquine for prevention of severe outcomes from COVID-19 are warranted. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342616por Öhrfelt, Annika, Dumurgier, Julien, Zetterberg, Henrik, Vrillon, Agathe, Ashton, Nicholas J., Kvartsberg, Hlin, Bouaziz-Amar, Elodie, Hugon, Jacques, Paquet, Claire, Blennow, Kaj“…The novel Ng assays are robust and highly sensitive and may be valuable tools to study synaptic alteration in AD, as well as to monitor the effect on synaptic integrity of novel drug candidates in clinical trials.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342617por Yamada, Takayuki, Wakabayashi, Mako, Bhalla, Abhinav, Chopra, Nitin, Miyashita, Hirotaka, Mikami, Takahisa, Ueyama, Hiroki, Fujisaki, Tomohiro, Saigusa, Yusuke, Yamaji, Takahiro, Azushima, Kengo, Urate, Shingo, Suzuki, Toru, Abe, Eriko, Wakui, Hiromichi, Tamura, Kouichi“…We selected randomized control trials that compared the risk of major adverse cardiovascular events (MACE) and a composite of renal outcomes. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342618por Walz, Lucas, Cohen, Avi J., Rebaza, Andre P., Vanchieri, James, Slade, Martin D., Dela Cruz, Charles S., Sharma, Lokesh“…RESULTS: Of 733 searched studies, we included four randomized and eleven non-randomized trials. Five of the studies were unpublished. Those who received Janus kinase-inhibitor had significantly reduced odds of mortality (OR, 0.12; 95% CI, 0.03–0.39, p< 0.001) and ICU admission (OR, 0.05; 95% CI, 0.01–0.26, p< 0.001), and had significantly increased odds of hospital discharge (OR, 22.76; 95% CI, 10.68–48.54, p< 0.00001) when compared to standard treatment group. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342619por Truong, Albert Yi-Que, Saway, Brian Fabian, Bouzaher, Malek H., Rasheed, Mustafa Nawroz, Monjazeb, Sanaz, Everest, Soleille Dorothy, Giampalmo, Susan Linda, Hartman, David, Hartman, Cheryl, Kablinger, Anita S., Trestman, Robert L.“…BACKGROUND: Clinical trials provide consistent evidence for buprenorphine’s efficacy in treating opioid use disorder (OUD). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342620por Weber, Manuel, Jentzen, Walter, Hofferber, Regina, Herrmann, Ken, Fendler, Wolfgang Peter, Rischpler, Christoph, Umutlu, Lale, Conti, Maurizio, Costa, Pedro Fragoso, Sraieb, Miriam, Kersting, David“…Especially a reduction of administered activity might allow for a lower radiation exposure and better health economics. Larger trials are warranted to confirm our results. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-020-07723-2.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto